B lock of cardiac sodium channels, a common mode of antiarrhythmic drug action, results in conduction slowing in the His-Purkinje system and ventricular muscle.' Ventricular muscle is highly anisotropic; that is, its electrophysiological properties are strongly dependent on the orientation of and connections between long, thin myocytes.2-4 When cardiac muscle is stimulated by a point source, impulses propagate two to three times faster in the longitudinal than in the transverse orientation, creating ellipsoidal isochrones. 4, 5 Cells are ordinarily well coupled end-to-end; longitudinal propagation is thought to be more dependent on the magnitude of the sodium current than is transverse propagation, which is thought to depend on the geometrical arrangement and extent of cell-cell coupling in the transverse orientation as well as on sodium current. 6 In experiments in which the effects of the sodium channel blockers on longitudinal and transverse propagation have been assessed, conduction is depressed in both orientations. In most studies, the extent of conduction slowing is greater in the longitudinal orientation, although the differences between drug effects in the two orientations are sometimes quite small. 8-'0 An agent that only slows conduction, particularly within a latent reentrant circuit, has the potential to enable rather than to suppress a reentrant tachycardia. The association between marked conduction slowing and ventricular tachycardia has long been recognized during treatment with sodium channel blockers. Indeed, the ventricular tachycardia associated with the class IC agents encainide and flecainide during the early 1980s1,'2 was also seen during the mid-1950s when high doses of quinidine were often used, particularly in the conversion of atrial fibrillation. 13 The administration of sodium as lactate, bicarbonate, or chloride can acutely reverse marked QRS prolongation seen as a consequence of sodium channel block, and this intervention can be antiarrhythmic. '4-20 
ODE Dosage Regimens
ODE (obtained from Bristol-Myers, Wallingford, Conn.) was infused as a series of loading and maintenance infusions designed to achieve stable plasma ODE concentrations during the maintenance period, thereby allowing assessment of the effects of sodium on ODEinduced conduction slowing. The low-dose regimen was a loading dose administered as a priming infusion of 17 ,ug/kg/min for 1.5 minutes followed by a second infusion of 12 ,g/kg/min for 13.5 minutes and a maintenance infusion of 6 ,g/kg/min. To achieve higher concentrations, the initial regimen was used with a 30-minute maintenance infusion and followed by a second loading dose administered as a priming infusion of 22.8 ,ug/kg/ min for 7.8 minutes followed by a second infusion of 17 ,g/kg/min for 7.2 minutes and a maintenance infusion of 12 ug/kg/min. All drug infusions were administered with a Harvard compact infusion pump (model 975). Conduction velocity was recorded at baseline and at least 30 minutes after the start of the maintenance infusion. We have used this method of administering ODE to study a series of studies of modulators of impulse initiation and propagation.25,26 For this report, we include data on the effects of ODE on conduction gathered in 25 animals in these studies as well as in 14 animals studied for the purposes of this report during both the low dose and the higher dose of ODE. In these 14 animals, the effects of sodium boluses during highmaintenance ODE concentrations were studied and are also reported.
Samples for subsequent analysis of plasma ODE were obtained during the maintenance infusion before and during the interventions described below. As well, samples for measurement of serum Na+ and K' were obtained during the study periods described below.
Administration of NaCI
Forty-five minutes after the beginning of the second maintenance infusion, a bolus of sodium chloride four times threshold) were delivered at a cycle length Figure 2 . Data from two animals with conduction block in the longitudinal orientation at high plasma ODE (484, 513 ng/ml) are not included in Figure 2 and are discussed further below. The left panel of Figure 2 shows that changes in 6LONG and s were both significantly correlated with plasma ODE; however, the concentration dependence of the changes in LONG was steeper than that for GRANs. For the 14 animals studied exclusively for the purposes of studying the effects of sodium on local conduction, the extents of decrease in OLONG and s were similarly highly correlated with plasma ODE (r=-0.76 and -0.79, respectively, both p<O.OOl). Inspection of the left panel suggests that the greatest differences between longitudinal and transverse changes were at the higher concentrations. The right panel shows the same data grouped by ODE concentrations c300 ng/ml (two thirds, 34 of 51 of the data sets) and those >300 ng/ml (highest third, 17 Figure 3 . Sodium chloride boluses transiently blunted the ODE-induced decrease in conduction velocity in both directions. As shown in Figure 3 , longitudinal conduction velocity was increased 29±7% and 31±6% (both p<0.05 versus before sodium) 5 minutes after the end of the first and second sodium chloride boluses, respectively. In the transverse orientation, the maximum increases were observed 1 minute after the end of each bolus and were 18±5% and 21±4% (both p<0.05) after the two boluses, respectively. Conduction velocity measured in the longitudinal direction 20 minutes after the end of the first sodium chloride bolus was still 20±5% higher than that measured before sodium, whereas in the transverse direction, conduction velocity Figure 4 illustrates signals recorded from each electrode in one dog at baseline, during the maintenance infusion of the low-dose and high-dose regimens, and 5 minutes after injection of a sodium chloride bolus. At the low ODE concentration (183 ng/ml), conduction slowed slightly in both directions, whereas at the higher concentration (513 ng/ml), propagation was slowed further in the transverse direction but was blocked in the longitudinal direction: The electrogram recorded from site 4 followed that from site 3, whereas the electrogram from site 2 preceded that from site 1. The electrograms from sites 1 and 2 were inverted; therefore, we conclude that impulses were initiated in the longitudinal direction at a point between sites 2 and 3. Because these records were derived by signal-averaging 10 consecutive complexes, we infer that this conduction block was stable (i.e., occurred with each beat). Administration of sodium chloride restored the normal sequence of impulse propagation in the longitudinal direction and increased conduction velocity in the transverse direction. This block of propagation in the longitudinal direction occurred in two of 11 experiments at ODE plasma concentrations >450 ng/ml but in none of 41 experiments when ODE concentrations were <450 ng/ml. Serum Na+ and K' concentrations just before the first sodium chloride bolus (140±3 meq/l and 3.5 ±0.2 meq/l) were not significantly different from those at baseline (141+±3 meq/l and 3.4±0.1 meq/l). Peak serum Na+ after the first sodium chloride bolus was 160±+2 meq/l at 1 minute and returned to 144±5 meq/l by 20 minutes. The second sodium bolus produced similar changes. As we have previously reported, serum K' fell significantly after sodium, reaching a low value of 1.8±+0.3 meq/l. Sodium boluses did not significantly change plasma ODE concentrations (464+32 ng/ml versus 420±17 ng/ml).
Discussion
We have previously shown that the sodium channel blockers mexiletine and quinidine, which were studied by methods similar to those described here, produce depression of conduction in both longitudinal and transverse orientations; in those experiments, depression of conduction by mexiletine (but not quinidine) was greater in the longitudinal orientation.10 Others have found similar results with procainamide,7 lidocaine,8 or amiodarone,9 although the difference between the extent of depression of longitudinal and transverse conduction is variable. We have now shown that disproportionate depression of longitudinal conduction by the class IC agent ODE occurs in a concentration-dependent fashion. Furthermore, our previous studies demonstrated that QRS and HV prolongation produced by ODE, like that produced by other sodium channel blockers such as quinidine, procainamide, or tricyclic antidepressants, can be acutely reversed by a sodium bolus.29 In the present study, sodium boluses acutely reversed slowing of local conduction, and this effect was more prominent in the longitudinal orientation ( Figures  3 and 4 ).
An advantage of our methods is an electrode array specifically designed to study anisotropic conduction. We use a small number of closely spaced bipoles whose alignment can be varied, as opposed to other studies in which an array of a larger number of bipoles spaced farther apart (2.5-5 mm) is placed over an area of interest. In all these methods, the calculation of a value for conduction velocity assumes a linear and constant conduction pathway. We recognize that these methods cannot measure discontinuities at the cellular level. However, because the electrograms do not display irregular contours, the recording sites are fairly close, and we are studying normal myocardium, we believe the use of the terms 6OtNG and OrRkNs are appropriate here.
Another advantage of our methods is the determination of conduction at stable plasma drug concentrations. This not only allows studies of an intervention such as sodium on drug-induced conduction slowing but also permitted us to generate the concentration-response data shown in Figure 2 . In a group of seven stable patients receiving long-term encainide, we found plasma ODE concentrations to vary from 63 to 381 ng/m130; plasma ODE concentrations in patients with excess sodium channel block and arrhythmias have not been reported but would presumably be higher. Thus, the concentration ranges in this report are relevant to those observed during encainide therapy.
The ionic mechanism of the effect of sodium is not known. In our previous studies, we considered the possibility that hypokalemia was responsible, perhaps by hyperpolarizing resting potential. Figure 4 do not allow us to delineate the pathway whereby impulses arrive between electrodes 2 and 3 in the longitudinal orientation: Propagation from transverse loci or transmyocardial conduction are possibilities. Such unidirectional block could, of course, serve to promote arrhythmias. Our finding that sodium boluses reverse this action further strengthens this hypothesis. In particular, we found that conduction was increased most in the longitudinal orientation, where it was most depressed by ODE. Thus, we believe that sodium controls arrhythmias that are caused by sodium channel blockers by preferentially enhancing longitudinal conduction, where it has been slowed to the greatest extent. The ionic mechanism underlying this beneficial action of sodium requires further study.
